Here are some take home messages from medical oncologist Dr. Sara Merler (IT) on her #EMUC23 lecture about how systematic treatment should be used for men with high-risk localised PCa in 2023. ESMO - Eur. Oncology ESTRO

Bellinzona and ⁦Ankara Üniversitesi⁩ getting together at EMUC! ⁦ESMO - Eur. Oncology⁩ ⁦European Association of Urology (EAU)⁩ ⁦ESTRO⁩ ⁦OncoAlert⁩ #emuc23 ⁦⁦silke gillessen⁩ ⁦Thomas Zilli⁩ ⁦Ursula Vogl⁩ ⁦Emre Yekedüz⁩ ⁦Advanced Prostate Cancer Consensus Conference⁩ and Sara Merler

Online Now: Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells dlvr.it/T3Tzrr

🌟 Be part of a pivotal moment in advanced #prostatecancer managment at #APCCC24! Join global experts in consensus discussions that shape future treatments. 🗓️ Register now for an unmissable experience: apccc.org #Oncology #GU24 #oncoalert

Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells dlvr.it/T5Fbdt

Part of my fantastic present, past and future #iosi young GU team #APCCC2024. All talented prostate cancer clinicians and researchers! Congrats silke gillessen - our medical director #iosi for a fantastic day 1! Fabio Turco @oncoalert Advanced Prostate Cancer Consensus Conference

Quel bambino ce l'ha fatta. That kid made it. Jannik #Sinner is the new world no. 1.

Fantastic day at #MCCR2024! Hard work and unforgettable moments Christophe Massard Benjamin Besse @ElenaGarralda Victor Moreno EORTC AACR ESMO - Eur. Oncology

Definitely the best event I’ve ever experienced. Thanks MCCR EORTC ! Amazing time and incredible faculty Christophe Massard Elena Frangou 🦢•🪴 Patrizia Giannatempo PDG3 rules! #MCCR24

Congratulations to silke gillessen and the team on the PEACE-3 study results! PEACE-3 trial shows a significant improvement in rPFS and OS with Enzalutamide + Ra223 in mCRPC with bone metastases. Time to SSE remained similar at 24 months (18%). #ESMO24 @oncoalert ESMO - Eur. Oncology

Chiara Ciccarese rocked the stage presenting preliminary data of TACITO trial investigating #FMT on #mRCC. Primary endpoint 1-y PFS met and no safety issues. Thanks to Gianluca Ianiro leading the gastroenterology team & all coinvesigators for this significant achievement. OncoAlert

I am so proud of being part of this amazing work from Alimonti’s lab! Great scientists, truly committed to prostate cancer research💪🏻

Great presentations at “Giornata della ricerca in Ticino” and amazing collaboration between IOSI and nuclear medicine at EOC. Excited to see more 🔜

Back from the magic Genève for an amazing #ESMOIO congress with my super ex-colleagues 🔝

10,000 patients worldwide! 🌍 We’ve reached a major milestone thanks to the incredible dedication of our global network. Thank you all! ❤️ #AronProject #10k #GlobalCollaboration

So honoured and grateful to share that I won the PIT grant award! Thrilled for the next steps!